Cancer treatment—other cancer treatment, text X[X(149)]
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Other cancer treatment description |
METEOR identifier:![]() | 561623 |
Registration status:![]() | Health, Standard 08/05/2014 |
Definition:![]() | The cancer-directed treatment administered during the course of treatment for cancer, other than surgery, radiotherapy or systemic therapy, as represented by text. |
Data Element Concept:![]() | Cancer treatment—other cancer treatment |
Value Domain:![]() | Other cancer treatment text X[X(149)] |
Value domain attributes | ||
Representational attributes | ||
Representation class:![]() | Text | |
---|---|---|
Data type:![]() | String | |
Format:![]() | X[X(149)] | |
Maximum character length:![]() | 150 |
Source and reference attributes | |
Submitting organisation:![]() | Cancer Australia |
---|
Data element attributes | |
Collection and usage attributes | |
Guide for use:![]() | This data item is to record cancer-directed treatments that cannot be appropriately assigned to the specific treatment codes in the cancer treatment data items for surgery, radiotherapy, systemic therapy agents and systemic therapy procedures. Cancer-directed treatments refer to those treatments that destroy or modify cancer tissue anywhere in the body. The exception to this is treatments for hematopoietic diseases (refer to additional notes below). Cancer-directed treatments may be palliative (to control symptoms, alleviate pain, or make the patient more comfortable) or curative. Record all other treatments administered during the course of treatment. Each treatment event delivered to the patient should be recorded; multiple entries are permitted. Record antibody treatments, vaccine treatments, and those targeted therapies that use drugs or substances other than chemotherapy agents in this data item. Targeted therapies using chemotherapy agents are recorded in the data items for chemotherapy. Targeted therapies are treatments that use drugs or other substances to identify and attack specific cancer cells. Do not record ancillary drugs. For example, allopurinol, which is commonly used as prophylaxis with chemotherapy agents to prevent severe hyperuricemia. A list of drugs regarded as ancillary is available in the SEER*Rx-Interactive Antineoplastic Drugs Database Version 1.4.1. Treatment events may include (for example):
|
---|---|
Collection methods:![]() | The information should be obtained from the patient’s medical record. |
Comments:![]() | Information on other cancer treatments is used to describe and evaluate the quality of care and treatment practices. |
Source and reference attributes | |
Submitting organisation:![]() | Cancer Australia |
Reference documents:![]() | American College of Surgeons 2002. Facility Oncology Registry Data Standards (FORDS), 2009 revision. Commission on Cancer American College of Surgeons 1998. Standards of the Commission on Cancer: Registry Operations and Data Standards (ROADS), Volume II. Commission on Cancer Johnson CH & Adamo M (Editors) 2007. SEER Program Coding and Staging Manual 2007, MD 2008 revision. Bethesda:National Cancer Institute, NIH Publication number 07-5581 |
Relational attributes | |
Related metadata references:![]() | Supersedes Cancer treatment—other cancer treatment, text [X(150)] Health, Superseded 08/05/2014 See also Cancer treatment—cancer treatment type, code N[N] Health, Standard 08/05/2014 See also Cancer treatment—surgical procedure for prostate cancer, code N Health, Standard 14/05/2015 |
Implementation in Data Set Specifications:![]() | Adolescent and young adult cancer (clinical) DSS Health, Superseded 14/05/2015 Conditional obligation: Complete when there is a first recurrence of cancer. DSS specific information: Complete this in relation to treatment for a first recurrence of cancer. Adolescent and young adult cancer (clinical) NBPDS Health, Standard 14/05/2015 Conditional obligation: Complete when there is a first recurrence of cancer. DSS specific information: Complete this in relation to treatment for a first recurrence of cancer. Cancer (clinical) DSS Health, Superseded 14/05/2015 Conditional obligation: Conditional on the patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set specification. Cancer (clinical) NBPDS Health, Standard 14/05/2015 Conditional obligation: Conditional on the patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set. Gynaecological cancer (clinical) DSS Health, Superseded 14/05/2015 Conditional obligation: This data element is to be recorded for a patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set specification. DSS specific information: This data element is to be used to describe treatment, other than surgery, radiotherapy or systemic therapy, used to treat a first recurrence of gynaecological cancer. Gynaecological cancer (clinical) NBPDS Health, Standard 14/05/2015 Conditional obligation: This data element is to be recorded for a patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set. DSS specific information: This data element is to be used to describe treatment, other than surgery, radiotherapy or systemic therapy, used to treat a first recurrence of gynaecological cancer. |